×
About 14,672 results

ALLMedicine™ Stents Center

Research & Reviews  6,973 results

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients w...
https://doi.org/10.1007/s11239-021-02439-x 10.1016/j.numecd.2015.01.009 10.1016/j.atherosclerosis.2015.03.030 10.1177/0003319716669429 10.1001/jamainternmed.2018.0514 10.1007/s11239-010-0451-y 10.1016/j.atherosclerosis.2013.05.024 10.1016/j.annemergmed.2008.08.033 10.1016/j.ijcard.2017.06.022 10.1016/j.ijcard.2011.11.102 10.1160/TH04-11-0726 10.1016/j.amjcard.2015.01.009 10.1001/jamainternmed.2014.4762 10.1016/j.amjcard.2012.12.011 10.1016/j.ahj.2004.05.018 10.1016/j.ahj.2004.10.044 10.5694/mja17.01109 10.1111/joic.12107 10.1016/j.jcin.2012.10.018 10.1016/j.ijcard.2018.02.095 10.1016/j.jcin.2009.09.015 10.1016/j.ijcard.2014.02.036 10.4244/EIJ-D-19-00539 10.1161/CIR.0b013e31826e1058 10.1161/CIRCULATIONAHA.106.685313 10.1161/CIRCULATIONAHA.110.009449 10.1016/j.ahj.2016.04.016 10.1177/0003319715586500 10.1056/NEJMoa1409312 10.1056/NEJMoa1500857 10.1016/j.jcin.2017.03.049 10.1097/FJC.0000000000000052 10.1016/j.jacc.2017.02.029 10.1093/ehjcvp/pvaa127 10.1093/ehjcvp/pvaa001 10.1016/j.jacc.2016.02.064 10.1007/s40265-013-0135-y 10.1186/s12872-017-0500-y 10.1016/j.hlc.2018.03.020 10.1016/j.amjcard.2016.11.034 10.1093/eurheartj/ehu075 10.1056/NEJMoa0706482 10.1161/CIRCINTERVENTIONS.116.003577 10.1007/s10557-016-6646-5 10.1016/j.ijcard.2017.05.091 10.1016/S0140-6736(01)05701-4
Journal of Thrombosis and Thrombolysis; Verdoia M, Suryapranata H et. al.

Apr 13th, 2021 - Gender differences in the thrombotic and bleeding risk have been suggested to condition the benefits of antithrombotic therapies in Acute Coronary Syndrome (ACS) patients, and mainly among those undergoing percutaneous coronary interventions with ...

Early coronary healing in ST segment elevation myocardial infarction: sirolimus-eluting...
https://doi.org/10.1097/MCA.0000000000001038
Coronary Artery Disease; García-Touchard A, Gonzalo N et. al.

Apr 7th, 2021 - Drug-coated balloons (DCBs) have theoretical advantages over drug-eluting stents (DESs) to facilitate stent healing. We studied whether, in patients undergoing primary coronary interventions (pPCIs), a strategy of DCB after bare-metal stent improv...

Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit ...
https://doi.org/10.1161/CIRCULATIONAHA.120.052482
Circulation Lansky AJ, Kereiakes DJ et. al.

Apr 6th, 2021 - Background: Accelerated endothelial healing after targeted antiproliferative drug delivery may limit the long-term inflammatory response of drug eluting stents (DES). The novel SupremeTM DES (Supreme) is designed to synchronize early drug delivery...

Colon or Rectal Stent Positioning for Advanced Cancer Influences Quality of Life: A Cri...
https://doi.org/10.21873/anticanres.14961
Anticancer Research; Fiori E, Crocetti D et. al.

Apr 4th, 2021 - Endoluminal self-expanding metallic stents (SEMS) may overcome the risk of mortality and morbidity of acute intestinal obstruction because of stage IV colon (CC) or rectal (RC) cancer. We evaluated the QoL in these groups of patients. Forty-eight ...

see more →

Guidelines  4 results

ASGE guideline on the role of endoscopy in the management of benign and malignant gastr...
https://doi.org/10.1016/j.gie.2020.07.063
Gastrointestinal Endoscopy; , Jue TL et. al.

Nov 10th, 2020 - This American Society for Gastrointestinal Endoscopy guideline provides evidence-based recommendations for the endoscopic management of gastric outlet obstruction (GOO). We applied the Grading of Recommendations, Assessment, Development and Evalua...

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
https://www.nejm.org/doi/full/10.1056/NEJMoa1909406

Sep 27th, 2019 - BACKGROUND Long-term outcomes after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents, as compared with coronary-artery bypass grafting (CABG), in patients with left main coronary artery disease are not clearly establi...

Esophageal stenting for benign and malignant disease: European Society of Gastrointesti...
https://doi.org/10.1055/s-0042-114210
Endoscopy Spaander MC, Baron TH et. al.

Sep 14th, 2016 - This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE), endorsed by the European Society for Radiotherapy and Oncology (ESTRO), the European Society of Digestive Endoscopy (ESDO), and the European Soci...

see more →

Clinicaltrials.gov  7,303 results

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients w...
https://doi.org/10.1007/s11239-021-02439-x 10.1016/j.numecd.2015.01.009 10.1016/j.atherosclerosis.2015.03.030 10.1177/0003319716669429 10.1001/jamainternmed.2018.0514 10.1007/s11239-010-0451-y 10.1016/j.atherosclerosis.2013.05.024 10.1016/j.annemergmed.2008.08.033 10.1016/j.ijcard.2017.06.022 10.1016/j.ijcard.2011.11.102 10.1160/TH04-11-0726 10.1016/j.amjcard.2015.01.009 10.1001/jamainternmed.2014.4762 10.1016/j.amjcard.2012.12.011 10.1016/j.ahj.2004.05.018 10.1016/j.ahj.2004.10.044 10.5694/mja17.01109 10.1111/joic.12107 10.1016/j.jcin.2012.10.018 10.1016/j.ijcard.2018.02.095 10.1016/j.jcin.2009.09.015 10.1016/j.ijcard.2014.02.036 10.4244/EIJ-D-19-00539 10.1161/CIR.0b013e31826e1058 10.1161/CIRCULATIONAHA.106.685313 10.1161/CIRCULATIONAHA.110.009449 10.1016/j.ahj.2016.04.016 10.1177/0003319715586500 10.1056/NEJMoa1409312 10.1056/NEJMoa1500857 10.1016/j.jcin.2017.03.049 10.1097/FJC.0000000000000052 10.1016/j.jacc.2017.02.029 10.1093/ehjcvp/pvaa127 10.1093/ehjcvp/pvaa001 10.1016/j.jacc.2016.02.064 10.1007/s40265-013-0135-y 10.1186/s12872-017-0500-y 10.1016/j.hlc.2018.03.020 10.1016/j.amjcard.2016.11.034 10.1093/eurheartj/ehu075 10.1056/NEJMoa0706482 10.1161/CIRCINTERVENTIONS.116.003577 10.1007/s10557-016-6646-5 10.1016/j.ijcard.2017.05.091 10.1016/S0140-6736(01)05701-4
Journal of Thrombosis and Thrombolysis; Verdoia M, Suryapranata H et. al.

Apr 13th, 2021 - Gender differences in the thrombotic and bleeding risk have been suggested to condition the benefits of antithrombotic therapies in Acute Coronary Syndrome (ACS) patients, and mainly among those undergoing percutaneous coronary interventions with ...

Early coronary healing in ST segment elevation myocardial infarction: sirolimus-eluting...
https://doi.org/10.1097/MCA.0000000000001038
Coronary Artery Disease; García-Touchard A, Gonzalo N et. al.

Apr 7th, 2021 - Drug-coated balloons (DCBs) have theoretical advantages over drug-eluting stents (DESs) to facilitate stent healing. We studied whether, in patients undergoing primary coronary interventions (pPCIs), a strategy of DCB after bare-metal stent improv...

Novel SupremeTM DES with Early Synchronized Antiproliferative Drug Delivery to Inhibit ...
https://doi.org/10.1161/CIRCULATIONAHA.120.052482
Circulation Lansky AJ, Kereiakes DJ et. al.

Apr 6th, 2021 - Background: Accelerated endothelial healing after targeted antiproliferative drug delivery may limit the long-term inflammatory response of drug eluting stents (DES). The novel SupremeTM DES (Supreme) is designed to synchronize early drug delivery...

Colon or Rectal Stent Positioning for Advanced Cancer Influences Quality of Life: A Cri...
https://doi.org/10.21873/anticanres.14961
Anticancer Research; Fiori E, Crocetti D et. al.

Apr 4th, 2021 - Endoluminal self-expanding metallic stents (SEMS) may overcome the risk of mortality and morbidity of acute intestinal obstruction because of stage IV colon (CC) or rectal (RC) cancer. We evaluated the QoL in these groups of patients. Forty-eight ...

see more →

News  391 results

Uncovered Self-Expandable Stent Likely Preferable for Malignant Gastric Outlet Obstruction
https://www.medscape.com/viewarticle/942099

Dec 7th, 2020 - NEW YORK (Reuters Health) - Covered and uncovered self-expandable metal stents (SEMS) for malignant gastric outlet obstruction show only minor differences, suggests a randomized trial in Japan. U.S. experts agree, noting that covered stents are no...

'Healing' Stent on Par With Durable Polymer Stents: PIONEER III
https://www.medscape.com/viewarticle/941517

Nov 23rd, 2020 - A novel stent designed to target early wound healing met the primary noninferiority end point at 1 year in the PIONEER III trial, but differentiating itself from current high-performing durable-polymer drug-eluting stents (DES) will require more. ...

Skinny Stent Falls Short in Noninferiority Trial, Troponin 'Noise' Blamed
https://www.staging.medscape.com/viewarticle/939527

Oct 20th, 2020 - The sirolimus-eluting Slender IDS coronary stent (Svelt Medical Systems), exquisitely skinny to simplify crossing lesions without predilatation, came up short in a randomized noninferiority trial against familiar Xience (Abbott Vascular) and Promu...

Skinny Stent Falls Short in Noninferiority Trial, Troponin 'Noise' Blamed
https://www.medscape.com/viewarticle/939527

Oct 20th, 2020 - The sirolimus-eluting Slender IDS coronary stent (Svelt Medical Systems), exquisitely skinny to simplify crossing lesions without predilatation, came up short in a randomized noninferiority trial against familiar Xience (Abbott Vascular) and Promu...

14-Day DAPT, COBRA PzF Stent Strike Out in COBRA-REDUCE
https://www.staging.medscape.com/viewarticle/939348

Oct 18th, 2020 - Dr Robert A. Byrne Coupling the Cobra PzF stent with just 14 days of dual-antiplatelet therapy (DAPT) fell short of expectations on two counts when pitted against contemporary drug-eluting stents (DES) and standard DAPT in high-bleeding risk patie...

see more →

Patient Education  1 results see all →